BondBloxx ETF Trust BondBloxx BBB Rated 10+ Year Corporate Bond ETF (ARCA: BBBL)

Latest news for BondBloxx ETF Trust BondBloxx BBB Rated 10+ Year Corporate Bond ETF (ARCA:BBBL)

The Fund is newly organized, non-diversified and seeks to track the investment results (i.e., the total return) of the Bloomberg US Corporate BBB 10+ Year Index (the Index) before fees and expenses of the Fund. The Index is designed to reflect the performance of BBB (or its equivalent) fixed-rate, taxable U.S. dollar-denominated corporate bonds issued by U.S. and non-U.S. industrial, utility and financial issuers (as determined by Bloomberg Index Services Limited (the Index Provider))

BondBloxx BBB Rated 10+ Year Corporate Bond ETF

BondBloxx ETF Trust BondBloxx BBB Rated 10+ Year Corporate Bond ETF

WIIM

SNAP

Shares of Snap and Meta are trading higher ahead of the TikTok ban deadline.

Morgan Stanley analyst Alexandra Steiger maintains Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) with a Equal-Weight and lowers the price target from $149 to $139.

News

Price Target

Analyst Ratings

Morgan Stanley Maintains Equal-Weight on Abercrombie & Fitch, Lowers Price Target to $139

Scotiabank analyst Ovais Habib maintains Equinox Gold (TSX:<a class="ticker" href="https://www.benzinga.com/stock/EQX#TSX">EQX</a>) with a Sector Perform and raises the price target from C$8.75 to C$9.

TSX:EQX

Scotiabank Maintains Sector Perform on Equinox Gold, Raises Price Target to C$9

Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) shares are trading higher on Wednesday.
Shares gained after NVIDIA Corp. announced its inaugural Quantum Day, <a target="_blank" href="https://www.benzinga.com/news/25/01/43001201/nvidia-announces-first-ever-quantum-day-at-gtc-2025-days-after-jensen-huang-said-quantum-computing-is-20-years-away" rel="noreferrer noopener">set to occur on March 20 during the GTC 2025 event</a>. The announcement comes just days after CEO&nbsp;Jensen Huang stated that practical quantum computing may&nbsp;still be two decades away.
Moreover, the announcement comes at a time when Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)&nbsp;declared to make its business clients&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/25/01/42998134/qubt-qbts-up-12-rgti-gains-3-in-wednesday-premarket-quantum-computing-stocks-gain-momentum-after-microsoft-says-we-are-right-on-the-cusp-of-seeing-quantum-computers-solve-meaningful-problems" rel="noreferrer noopener">&#8220;quantum-ready&#8221; by 2025</a>.
Quantum Computing has not been the only company to see significant gains; other companies, like D-Wave Quantum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>), have also experienced significant gains. This surge underscores the growing anticipation and investment in quantum computing technologies.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43002269/crowdstrike-unveils-insider-risk-services-to-reduce-millions-of-dollars-in-costs-from-insider-threats" rel="noreferrer noopener">CrowdStrike Unveils Insider Risk Services To Reduce Costs From Insider Threats: Details</a>
Meanwhile, Quantum Computing has partnered with Sanders Tri-Institutional Therapeutics Discovery Institute to <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n43001080/quantum-computing-inc-announces-collaboration-with-sanders-tri-institutional-therapeutics-discover" rel="noreferrer noopener">advance research in computational biomedicine.</a>
Quantum Computing will provide Sanders TDI access to its Dirac-3 Entropy Quantum Computing Machine, enabling the institute to leverage quantum computing for complex biomedical challenges.
Sanders TDI, a collaboration of certain New York research institutions, focuses on drug discovery and disease progression. The partnership will utilize quantum technology for biomolecular modeling, exploring potential applications in computational chemistry.
William McGann, CEO of Quantum Computing, highlighted the collaboration as a key step in making quantum computing accessible for real-world applications in healthcare.
&#8220;It aligns perfectly with our mission to make quantum machines accessible and affordable and is one of the many real-world applications where the power of quantum computing is being demonstrated and put into practice by QCi,&#8221; McGann said.
Price Action: QUBT shares are trading higher by 33% to $9.88 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/01/42967576/meta-investors-push-mark-zuckerberg-to-replace-72b-cash-with-bitcoin-to-combat-inflation-heres-what-it-means-for-investors" target="_blank" rel="noreferrer noopener">Meta Investors Push Mark Zuckerberg To Replace $72B Cash With Bitcoin To Combat Inflation: Here&#8217;s What It Means For Investors</a></li>
</ul>
Image via Shutterstock.

Equities

Markets

Movers

Tech

General

MSFT

QBTS

QUBT

What's Going On With Quantum Computing Stock Today?

Morgan Stanley analyst Matthew Harrison maintains Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) with a Equal-Weight and lowers the price target from $70 to $38.

MRNA

Morgan Stanley Maintains Equal-Weight on Moderna, Lowers Price Target to $38

AFRM

Affirm shares are trading higher after William Blair initiated coverage on the stock with an Outperform rating.

Scotiabank analyst Ovais Habib maintains Dundee Precious Metals (TSX:<a class="ticker" href="https://www.benzinga.com/stock/DPM#TSX">DPM</a>) with a Sector Outperform and raises the price target from C$18 to C$18.5.

TSX:DPM

Scotiabank Maintains Sector Outperform on Dundee Precious Metals, Raises Price Target to C$18.5

RBC Capital analyst Luca Issi reiterates Ionis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONS#NASDAQ">IONS</a>) with a Outperform and maintains $70 price target.

Reiteration

IONS

RBC Capital Reiterates Outperform on Ionis Pharmaceuticals, Maintains $70 Price Target

CBRE

CBRE Group shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $115 to $160.

Trading Ideas

MITQ

Moving iMage Technologies Shares Halted On Circuit Breaker To The Upside, Stock Now Up 80.5%

SOFI

SoFi Technologies shares are trading higher after William Blair initiated coverage on the stock with an Outperform rating.

OSTX

OS Therapies Shares Halted On Circuit Breaker To The Downside, Stock Now Up 9.62%

Edison International shares are trading higher after Ladenburg Thalmann upgraded the stock from Sell to Neutral.

Tempus AI shares are trading higher after the company announced the launch of its FDA-approved xT CDx test for clinicians nationwide.

RBC Capital analyst Gregory Renza reiterates IDEAYA Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) with a Outperform and maintains $61 price target.

IDYA

RBC Capital Reiterates Outperform on IDEAYA Biosciences, Maintains $61 Price Target

PHIO

Phio Pharmaceuticals shares are trading lower after the company announced a $2.5 million registered direct offering.

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 600 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 1.43% to 43,130.23 while the NASDAQ rose 1.62% to 19,353.59. The S&amp;P 500 also rose, gaining, 1.33% to 5,920.50.
Check This Out: <a href="https://www.benzinga.com/25/01/42998360/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Consumer discretionary shares rose by 2.2% on Tuesday.
In trading on Tuesday, health care shares fell by 0.4%.
Top Headline
The headline Consumer Price Index rose 2.9% year-over-year in December, according to Wednesday's data from the Bureau of Labor Statistics. This marks an increase from November&#8217;s 2.7% and matches economist forecasts. Notably, it represents the third straight inflation increase and highest annual rate since July 2024.
On a monthly basis, consumer prices increased 0.4%, up from both the previous month&#8217;s 0.3% gain and the 0.3% predicted by analysts.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Safe &amp; Green Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares shot up 176% to $1.4899. Safe &amp; Green Holdings announced the execution of a binding Letter of Intent to acquire 100% of the outstanding securities of New Asia Holdings Inc.</li>
<li>Shares of Vision Marine Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>)got a boost, surging 58% to $2.21 after the company announced it filed its latest patent application with the United States Patent and Trademark Office for a Battery Authentication Encryption Technology.</li>
<li>Moving iMage Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#NYSE">MITQ</a>) shares were also up, gaining 68% to $1.21.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Meiwu Technology Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) shares dropped 63% to $0.35.</li>
<li>Shares of Aclarion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) were down 62% to $0.0367 after the company reported the pricing of $14.4m public offering of common stock and warrants.</li>
<li>Azitra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#NYSE">AZTR</a>) was down, falling 40% to $0.2530 after the company announced the pricing of a $1.5 million public offering.</li>
</ul>
Commodities In commodity news, oil traded up 1.2% to $78.41 while gold traded up 0.8% at $2,702.50.
Silver traded up 2% to $30.970 on Wednesday, while copper rose 0.7% to $4.3735.
Euro zone
European shares were higher today. The eurozone's STOXX 600 surged 1.2%, Germany's DAX 40 gained 1.6% and France's CAC 40 gained 1%. Spain's IBEX 35 Index gained 1.2%, while London's FTSE 100 gained 0.9%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 falling 0.08%, China's Shanghai Composite Index declining 0.43%, Hong Kong's Hang Seng Index gaining 0.34% and India's BSE Sensex rising 0.29%.
Economics
The headline Consumer Price Index rose 2.9% year-over-year in December, according to Wednesday's data from the Bureau of Labor Statistics.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42997542/top-3-tech-and-telecom-stocks-that-may-explode-this-quarter">Top 3 Tech And Telecom Stocks That May Explode This Quarter</a></li>
</ul>

Earnings

Eurozone

Commodities

Intraday Update

ACON

AZTR

SGBX

VMAR

Dow Jumps 600 Points; US Inflation Increases To 2.9% In December

Scotiabank analyst Ovais Habib maintains Centerra Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CGAU#NYSE">CGAU</a>) with a Sector Outperform and lowers the price target from $10 to $9.

CGAU

Scotiabank Maintains Sector Outperform on Centerra Gold, Lowers Price Target to $9

XXII

22nd Century Group shares are trading higher after the FDA announced it proposed significant step towards reducing nicotine to minimally or nonaddictive level in cigarettes and other combusted tobacco products.

One question that consistently comes across my desk is why we maintain a global value portfolio when growth stocks and U.S. markets are clearly dominating the investment landscape. The answer, quite frankly, is that&#8217;s exactly why we&#8217;re doing it.
The United States has maintained its position as the world&#8217;s dominant economy and market for some time, but this dominance has intensified significantly in the aftermath of the COVID pandemic. Our leadership in implementing relief funds, stimulus programs, interest rate management to combat inflation, and supply chain repairs has been unmatched. Add to this our current supremacy in artificial intelligence development (at least among public companies), and it&#8217;s no surprise that U.S. markets now represent about 70% of global market capitalization.
However, this dominance comes at a price. U.S. stocks are trading at significantly higher multiples of earnings, asset values, and dividends compared to many international markets, where valuations are often half of what we&#8217;re seeing domestically. While these markets may be out of favor, history has consistently shown that the most successful investors are those willing to venture where others fear to tread.
The Value of Contrarian Investing Looking back at market history, some of the most profitable opportunities have emerged from moments of market distress. Consider the crash of 1987 &#8211; investors who had the courage to buy during or shortly after the crash reaped substantial gains. Similar opportunities presented themselves during the S&amp;L crisis with healthy banks, in the aftermath of the junk bond implosion following Drexel Burnham&#8217;s collapse, and during the tech sector&#8217;s meltdown in 2002-2003.
Yes, there&#8217;s always the possibility that buying into dire situations could result in massive losses if the world truly implodes. But at that point, your stock portfolio&#8217;s performance would likely be the least of your concerns.
Current Global Market Dynamics Europe currently presents what many view as a challenging investment landscape. The Japanese political and economic situation continues to perplex observers, particularly given their substantial debt-to-GDP ratio. However, Japan continues to not just survive but thrive, and we&#8217;re witnessing unprecedented success in corporate activism campaigns across Asia, particularly in Japan, where efforts to unlock shareholder value are gaining traction.
This global approach isn&#8217;t new. John Templeton pioneered this strategy, famously launching his career by borrowing $10,000 to purchase a portfolio of NYSE-listed stocks trading under $1. While some went bankrupt, the portfolio quadrupled over several years, marking the beginning of his illustrious career. Templeton went on to become a trailblazer in global value investing, achieving impressive compounded returns over a long career.
The Perfect Stock Portfolio&#8217;s Global Perspective Our portfolio&#8217;s international approach has proven highly profitable over the years. We&#8217;ve successfully invested in Russian steel companies, banks, and mining operations, South African diamond mines, Indian conglomerates, European banks, and British bakeries. By maintaining a global perspective while adhering to our core criteria &#8211; reasonable valuations, dividend payments, and conservative finances &#8211; we&#8217;ve significantly enhanced our returns.
Currently, finding stocks in the U.S. that trade below asset value, maintain strong balance sheets with minimal debt, offer reasonable yields, and remain profitable is increasingly challenging. In contrast, Europe and Japan present numerous opportunities meeting these criteria. We&#8217;ve even identified select Chinese companies that qualify under our stringent standards.
Regional Market Analysis The Chinese market remains a significant concern for global investors. Growth projections indicate a slowdown to 4.5% in 2025 from nearly 5% last year, with further deceleration expected in 2026. This situation could worsen if Donald Trump implements his proposed tariffs. However, Xi Jinping&#8217;s government is discussing various stimulus measures, including property market support, increased debt issuance, and potential interest rate and reserve requirement adjustments by the People&#8217;s Bank of China. European markets present an interesting value proposition despite lagging U.S. growth. Unlike the U.S., European markets are heavily weighted toward financials, energy, and industrials rather than tech giants (with notable exceptions like ASML). While their renewable energy initiatives haven&#8217;t fully delivered, the sector maintains growth potential. European markets currently trade at roughly half the valuation levels of U.S. stocks while offering higher dividend yields.
Japan's market dynamics remain complex but promising. Despite challenges including high government debt and an aging population, they&#8217;ve maintained stability. Recent developments include potential rate hikes amid inflationary pressures and wage growth. The government&#8217;s $250 billion stimulus package, focusing on digital innovation and energy cost subsidies, has received positive market response. Many analysts anticipate the Nikkei 225 reaching new all-time highs this year.
New Portfolio Addition: Peabody Energy Corporation (Ticker: BTU) Despite our international focus, our latest addition is a U.S.-based company in perhaps the most unloved sector globally &#8211; coal. Peabody Energy Corporation, headquartered in St. Louis, operates globally, serving customers in 25 countries with both thermal and metallurgical coal.
Their recent $3.8 billion acquisition of Anglo-American&#8217;s Australian steelmaking coal assets is transformative, potentially tripling their metallurgical coal production by 2026. While developed markets are transitioning away from thermal coal, demand remains strong in emerging markets, particularly China and India. Additionally, coal still generates approximately 20% of U.S. electricity.
Peabody&#8217;s fundamentals are compelling:
<ul>
<li>Annual revenue exceeding $1 billion</li>
<li>Substantial free cash flow</li>
<li>Strong liquidity</li>
<li>Manageable debt levels</li>
<li>1.63% dividend yield</li>
<li>Trading at approximately 5x earnings</li>
<li>75% of tangible book value</li>
</ul>
While the coal industry faces regulatory and environmental headwinds in Western markets, global demand persists, particularly in emerging economies. The Perfect Stock Portfolio continues to focus on dividend collection and deeply undervalued stocks, maintaining our strategy of beating the markets through patient, value-oriented investing.

Opinion

The Case for Global Value Investing: January 2025 Perfect Stocks Report

Comments

BondBloxx ETF Trust BondBloxx BBB Rated 10+ Year Corporate Bond ETF

News

Latest news for BondBloxx ETF Trust BondBloxx BBB Rated 10+ Year Corporate Bond ETF (ARCA:BBBL)

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga